Previous page Next page

iEmoji Feeds @Rebecca Shatsky, MD (Dr_RShatsky)

1.

Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
I have about 5 talks to give in the next few weeks that I have not made the slides for I seriously can only functi… twitter.com/i/web/status/1…
24 Feb 23 copy & paste +upvote -downvote I have about 5 talks to give in the next few weeks that I have not made the slides for 😬I seriously can only functi… https://t.co/dPNVCAwHAJ

2.

Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Very young women do poorly from #Breastcancer . Here we characterise oncogenic drivers from >1200 patients BC sa… twitter.com/i/web/status/1…
Retweet of status by @LoiSher
03 Feb 23 copy & paste +upvote -downvote 🚩Very young women do poorly from #Breastcancer 🤔. Here we characterise oncogenic drivers from >1200 patients BC sa… https://t.co/ISY42cWygM
3.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Something I think we at #SABCS22 can all agree on. @FAndreMD is delightful. Wonderful speaker, clear, brilliant and so much fun. #bcsm
08 Dec 22 copy & paste +upvote -downvote Something I think we at #SABCS22 can all agree on. @FAndreMD is delightful. Wonderful speaker, clear, brilliant and so much fun. ☺️#bcsm
4.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Hot Off The Press | Patients with #InflammatoryBreastCancer, particularly those with metastatic and/or triple-neg… twitter.com/i/web/status/1…
Retweet of status by @JournalCancer
10 Oct 22 copy & paste +upvote -downvote 📢 Hot Off The Press | Patients with #InflammatoryBreastCancer, particularly those with metastatic and/or triple-neg… https://t.co/miejIeo538
5.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Ok medicine we really need to start respecting vacation as a sacred time where email replies are NOT expected. Our… twitter.com/i/web/status/1…
05 Aug 22 copy & paste +upvote -downvote 🧵Ok medicine we really need to start respecting vacation as a sacred time where email replies are NOT expected. Our… https://t.co/syXxY1rMTO
6.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Clinical trials eligibility a . I’ve had several encounters recently that show me that the majority of the public,… twitter.com/i/web/status/1…
02 Mar 22 copy & paste +upvote -downvote Clinical trials eligibility a 🧵. I’ve had several encounters recently that show me that the majority of the public,… https://t.co/Oiu3IGuNpM
7.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Also I meant “how did this,” I promise English is not my second language. I just have fat fingers.
17 Oct 21 copy & paste +upvote -downvote Also I meant “how did this,” I promise English is not my second language. I just have fat fingers. 😳
8.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
With recent shocks in the TNBC IO field, it’s a good time to re-check this great analysis by @hoperugo & al

22C3+… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
29 Aug 21 copy & paste +upvote -downvote With recent shocks in the TNBC IO field, it’s a good time to re-check this great analysis by @hoperugo & al 👉22C3+… https://t.co/8GyvZ6wvX4
9.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Just out on Annals the biomarker analysis from #ASCENT

message: Sacituzumab govitecan outperforms chemo in ever… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
09 Jun 21 copy & paste +upvote -downvote Just out on Annals the biomarker analysis from #ASCENT 🔑 message: Sacituzumab govitecan outperforms chemo in ever… https://t.co/7d6hgUcaAW
10.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Fairly impressive preliminary results of the anti-Trop2 ADC Datopotamab-DXd in TNBC

ORR 43%, DCR 95%

No drug-… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
08 May 21 copy & paste +upvote -downvote 🔥 Fairly impressive preliminary results of the anti-Trop2 ADC Datopotamab-DXd in TNBC ORR 43%, DCR 95%‼️ No drug-… https://t.co/HyxtxSrcMp
11.
Dr_RShatsky
Rebecca Shatsky, MD @Dr_RShatsky
Few fields in oncology are moving as fast as HER2+ BC

4 new drugs have been approved within 1 single year
drugs… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
23 Mar 21 copy & paste +upvote -downvote Few fields in oncology are moving as fast as HER2+ BC 👉4 new drugs have been approved within 1 single year 👉drugs… https://t.co/SaHBDJXZmt

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
Previous page Next page
https://www.iemoji.com/feed/Dr_RShatsky
Back to top